Back to top
more

Edwards Lifesciences (EW)

(Delayed Data from NYSE)

$63.74 USD

63.74
9,888,884

+1.37 (2.20%)

Updated Jul 29, 2024 04:00 PM ET

After-Market: $63.73 -0.01 (-0.02%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.03%
2Buy17.70%
3Hold9.37%
4Sell5.03%
5Strong Sell2.48%
S&P50011.19%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value D Growth B Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 40% (100 out of 251)

Industry: Medical - Instruments

Better trading starts here.

Zacks News

Illumina (ILMN) Rides on New Products, Low Margin a Concern

Illumina (ILMN) continues to grow in high-potential genetic research market through innovation and product launches.

    Bruker (BRKR) Q2 Earnings & Revenues Beat Estimates, View Up

    Bruker (BRKR) delivers a better-than-expected Q2, largely driven by strength in CALID Group and BEST. Moreover, a raised guidance buoys optimism.

      Hologic (HOLX) Beats on 3Q Earnings, Cuts Revenue Guidance

      Hologic's (HOLX) revenue growth in molecular diagnostics and GYN Surgical offset by poor blood screening and Breast Imaging show.

        Cardiovascular Systems (CSII) Posts Q4 Earnings, Revenues Top

        Cardiovascular Systems' (CSII) lower operating expenses drove the year-over-year improvement in Q4 earnings.

          Genomic Health (GHDX) Posts Wider-than-Expected Loss in Q2

          Genomic Health (GHDX) continues to lag expectations despite strong adoption of its Oncotype DX test.

            ResMed (RMD) Q4 Earnings Top, 2020 Strategic Goals on Track

            ResMed's Q4 results (RMD) register strong sales in sleep devices, respiratory care devices, mask systems and software solutions.

              Tirthankar Chakraborty headshot

              New Strong Buy Stocks for August 1st

              Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Tuesday

                C.R. Bard (BCR) Beats Earnings & Revenue Estimates in Q2

                C.R. Bard's (BCR) solid performance in the Vascular, Urology and Surgical Specialties were the key highlights of the second quarter.

                  Edwards Lifesciences (EW) Tops Q2 Earnings & Sales, View Up

                  Edwards Lifesciences (EW) rides high on continued growth in its highly advanced Transcatheter Heart Valve space in Q2.

                    Edwards Lifesciences (EW) Q2 Earnings: A Surprise in Store?

                    Edwards Lifesciences (EW) will likely ride high in Q2 earnings banking on continued growth in its highly advanced Transcatheter Heart Valve space.

                      Haemonetics Plasma Arm Advances, Blood Center Sluggish

                      On Jul 13, we issued an updated research report on Haemonetics Corporation (HAE).

                        BioTelemetry (BEAT) Acquires LifeWatch for $280 Million

                        BioTelemetry Inc. (BEAT) enhances its position in the wireless medicine space, enlarges product profile and customer base in cardiac monitoring and diagnostic services with LifeWatch buyout.

                          Avantor to Acquire VWR, Consolidation Promises Global Gains

                          On Jul 14, we issued an updated research report on Radnor, PA-based VWR Corporation (VWR).

                            DaVita Medical Group Buys Dr. Rahn Shaw Practices in Orlando

                            DaVita Inc. (DVA) recently acquired Dr. Rahn Shaw's practices, Park Avenue Medical, Inc. and Winter Park Health Center, Inc., each located in Orlando.

                              Zimmer Biomet's Preliminary Q2 Numbers Solid, CEO Steps Down

                              Indiana-based Zimmer Biomet Holdings, Inc. (ZBH), a leading player in the global musculoskeletal space, recently announced second-quarter 2017 preliminary results.

                                DENTSPLY SIRONA Strong on Deal Renewals, Forex Woes Stay

                                On Jul 12, we issued an updated research report on NY-based DENTSPLY SIRONA Inc. (XRAY) -- a global leader in the design, development, manufacture and marketing of dental consumables and dental laboratory products.

                                  McKesson (MCK) Poised on Improving Generic and Brand Market

                                  On Jul 12, we issued an updated research report on San Francisco, CA-based McKesson Corporation (MCK).

                                    LabCorp Diagnostics Strong on Novant Health Deal Extension

                                    Laboratory Corporation of America Holdings (LH), also referred to as LabCorp, has decided to extend its Technical Services Agreement with Novant Health which was originated in 2012.

                                      CVS Health's MinuteClinic Joins EOHN for Workplace Healthcare

                                      MinuteClinic, the retail medical clinic of CVS Health Corporation (CVS), announced a tie-up with the Alere eScreen Occupational Health Network.

                                        Express Scripts Rides High on Increased Generic Utilization

                                        On Jul 10, we issued an updated research report on St. Louis, MO-based pharmacy benefit manager Express Scripts Holding Company (ESRX).

                                          PAREXEL (PRXL) Gets CEO Cancer Gold Standard Accreditation

                                          PAREXEL International Corporation (PRXL) was recently nominated as a CEO Cancer Gold Standard employer by CEO Roundtable on Cancer.

                                            Neogen Introduces Test for Listeria in Environmental Samples

                                            Neogen Corporation (NEOG) recently developed Listeria Right Now test system.

                                              MedTech Industry Outlook - July 2017

                                              The overall expectation is that President Trump's legislative change for MedTech will result in lower taxes and regulation for the industry as a whole.

                                                Panel Of Zacks Experts headshot

                                                Top Stock Picks for the Week of May 29th

                                                A Value and Medical Growth Play to Consider.

                                                  Why Is Edwards Lifesciences (EW) Up 4.5% Since the Last Earnings Report?

                                                  EW reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.